Thinking of joining a study?

Register your interest

NCT06761768 | NOT YET RECRUITING | Sacroiliac Joint Dysfunction


Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain
Sponsor:

Tri-Service General Hospital

Information provided by (Responsible Party):

l iang-Cheng Chen

Brief Summary:

This study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain.

Condition or disease

Sacroiliac Joint Dysfunction

Sacroiliac Joint Pain

Intervention/treatment

Corticosteroids Triamcinolone Acetonide

extracorporeal shockwave

extracorporeal shockwave(minimum intensity)

Phase

NA

Detailed Description:

The most common primary cause of pain and stiffness from the SIJ is sacroiliac joint dysfunction. Currently, conservative treatments for SIJ dysfunction-related pain include oral anti-inflammatory pain medications, exercise therapy, physical therapy, and local injection therapies such as corticosteroids, dextrose, and platelet-rich plasma. Although there are multiple non-surgical options available for SIJ pain management, clear treatment guidelines have not yet been established. Among these options, intra-articular corticosteroid injections in the SIJ are frequently used by rehabilitation specialists in clinical practice, and their effectiveness in relieving pain from SIJ dysfunction has been demonstrated. However, the effects of corticosteroids in treating musculoskeletal-related diseases are typically short-term. Extracorporeal shock wave therapy (ESWT) has become increasingly common in the management of musculoskeletal conditions such as calcific tendinitis, tennis elbow, and plantar fasciitis, showing long-lasting benefits and inducing tissue repair responses that studies suggest may last up to two years. However, literature on ESWT for lower back pain is limited, and research on its use for SIJ pain is even rarer. Therefore, this study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain, aiming to achieve rapid, short-term pain relief through corticosteroid injections, followed by potential long-term effects through ESWT.

Study Type : INTERVENTIONAL
Estimated Enrollment : 44 participants
Masking : SINGLE
Primary Purpose : TREATMENT
Official Title : Efficacy of Combining Corticosteroid Injections and Extracorporeal Shockwave Therapy in Patients With Sacroiliac Joint Pain
Actual Study Start Date : 2025-08-01
Estimated Primary Completion Date : 2026-07-01
Estimated Study Completion Date : 2026-07-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 20 Years to 75 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Low back pain lasting for 3 months or more
  • * Pain VAS score of 4 or higher
  • * Three or more positive results in sacroiliac joint provocation tests
  • * At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic
Exclusion Criteria
  • * Currently undergoing extracorporeal shockwave therapy in other areas
  • * Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis/disc degeneration, hip arthritis)
  • * Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression
  • * Sacroiliac joint injection therapy received within the past 6 months
  • * Contraindications for extracorporeal shockwave therapy (e.g., cancer or current/prior infections at the treatment site, pacemakers, pregnancy, epilepsy, or coagulation disorders caused by disease or medication)
  • * Impaired renal function preventing the administration of contrast agents for sacroiliac joint bone scanning

Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain

Location Details

NCT06761768


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...